An Alabama-based doctor has been sentenced in federal court in Boston for a $2.7 million telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME) and genetic testing primarily used to detect mutations in genes that could indicate a higher risk of developing certain types of cancers. Tommie Robinson, 44, was sentenced on March 20, 2026 to 16 months in prison, to be followed by one year of supervised release. Robinson was also ordered to pay $2,784,733.49 in restitution. Between December 2018 and March 2021, Robinson worked with telemedicine companies to sign medical documentation, including doctors’ orders, for medically unnecessary durable medical equipment and genetic testing.
The orders Robinson signed were pre-populated based on telemarketing calls made to Medicare beneficiaries. Robinson generally did not contact the beneficiaries himself and had no provider-patient relationship with the beneficiaries. DME suppliers and laboratories ultimately submitted claims to Medicare for these signed orders. As a result of Robinson’s participation in this scheme, the suppliers and laboratories submitted over $2.7 million in claims to Medicare for DME and genetic testing that were medically unnecessary and based on false documentation.